Manager Quality Assurance

The Purpose

Participating in defining overall strategy for Quality Management within CiMaas and for implementing, maintaining and improving a Quality System for CiMaas in compliance with the EU GMP guidelines.

The Challenge

  • Ensure a high level of GMP compliance throughout the entire organization and define actions for continuous improvement by setting out directives for Quality Management.
  • Ensuring that the Quality system complies with international guidelines, directives and regulations as required.
  • Maintaining state of the art quality systems e.g. for non-conformances, CAPA, change control, supplier auditing.
  • Keeping up to date with respect to new regulations, new GMP and other guidelines and publications.
  • Establish Quality Agreements with clients and contractors.
  • Responsible for all contacts with regulatory bodies with regards to GMP related issues and filings.
  • Coordinate interactions with other departments and external parties.
  • Assure permanent availability of qualified personnel within QA by developing and coordinating training programs for QA employees.
  • Lead and coach employees of the QA department.

The required Knowledge, skills, and competences

  • BSc/MSc in chemistry/biotechnology plus extensive relevant biotechnological Quality Assurance and GMP training.
  • Experience in implementing the QMS.
  • Preferably 3-5 years’ experience in laboratorial Quality Control.
  • Managerial experience.
  • Excellent communication skills in English.
  • Leadership, accuracy, planning and organization, initiative, resourcefulness.

The offer

We offer you an employment contract with a level matching salary for a period of one year, with the possibility of extension and competitive market-oriented secondary benefits. The location is Geleen.

Are you interested?

Send your CV and extended letter of motivation to:

CiMaas BV
Suzanne Eussen, Office Manager
Oxfordlaan 70
6229 EV Maastricht
the Netherlands

T: +31 43 3 88 58 16

E: vacature at

For substantive questions, please contact:
Prof Dr Gerard Bos, CEO via